Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: an expert consensus

J Neurol. 2021 Apr;268(4):1540-1543. doi: 10.1007/s00415-021-10466-0. Epub 2021 Feb 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Consensus
  • Humans
  • Influenza Vaccines*
  • Multiple Sclerosis* / drug therapy
  • Seasons

Substances

  • Antibodies, Monoclonal, Humanized
  • Influenza Vaccines
  • ocrelizumab